BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy9323
(289 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2Y00|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Partial Agonist Dobutamine (Crystal
Dob92)
pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Partial Agonist Dobutamine (Crystal
Dob92)
pdb|2Y01|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Partial Agonist Dobutamine (Crystal
Dob102)
pdb|2Y01|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Partial Agonist Dobutamine (Crystal
Dob102)
pdb|2Y02|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Agonist Carmoterol
pdb|2Y02|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Agonist Carmoterol
pdb|2Y03|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Agonist Isoprenaline
pdb|2Y03|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Agonist Isoprenaline
pdb|2Y04|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Partial Agonist Salbutamol
pdb|2Y04|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Partial Agonist Salbutamol
pdb|4AMI|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Biased Agonist Bucindolol
pdb|4AMI|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Biased Agonist Bucindolol
pdb|4AMJ|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Biased Agonist Carvedilol
pdb|4AMJ|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Biased Agonist Carvedilol
Length = 315
Score = 159 bits (401), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 76/188 (40%), Positives = 118/188 (62%), Gaps = 1/188 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+ GN+LVI ++ ++L+ +TN F+ SLA AD++V + F ++ + WL+G F+C+
Sbjct: 26 VAGNVLVIAAIGSTQRLQTLTNLFITSLACADLVVGLLVVPFGATLVVRGTWLWGSFLCE 85
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
+W SLDV +ASI LC I++DRY AI P Y +MT++R +++C VW ALVSFL
Sbjct: 86 LWTSLDVLCVTASIETLCVIAIDRYLAITSPFRYQSLMTRARAKVIICTVWAISALVSFL 145
Query: 223 PIFLGWYTTHAHQLFRS-HNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + W+ Q + +P C FV NR Y + SS +SF+IP +IMI++ ++Y+EA
Sbjct: 146 PIMMHWWRDEDPQALKCYQDPGCCDFVTNRAYAIASSIISFYIPLLIMIFVALRVYREAK 205
Query: 282 RQEHMLFR 289
Q + R
Sbjct: 206 EQIRKIDR 213
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Cyanopindolol
pdb|2VT4|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Cyanopindolol
pdb|2VT4|C Chain C, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Cyanopindolol
pdb|2VT4|D Chain D, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Cyanopindolol
pdb|2YCW|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Carazolol
pdb|2YCW|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Carazolol
pdb|2YCX|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Cyanopindolol
pdb|2YCX|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Cyanopindolol
pdb|2YCZ|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Iodocyanopindolol
pdb|2YCZ|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Iodocyanopindolol
pdb|2YCY|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Cyanopindolol
pdb|2YCY|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising
Mutations And Bound Antagonist Cyanopindolol
pdb|4GPO|A Chain A, Oligomeic Turkey Beta1-adrenergic G Protein-coupled
Receptor
pdb|4GPO|B Chain B, Oligomeic Turkey Beta1-adrenergic G Protein-coupled
Receptor
Length = 313
Score = 159 bits (401), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 76/188 (40%), Positives = 118/188 (62%), Gaps = 1/188 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+ GN+LVI ++ ++L+ +TN F+ SLA AD++V + F ++ + WL+G F+C+
Sbjct: 26 VAGNVLVIAAIGSTQRLQTLTNLFITSLACADLVVGLLVVPFGATLVVRGTWLWGSFLCE 85
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
+W SLDV +ASI LC I++DRY AI P Y +MT++R +++C VW ALVSFL
Sbjct: 86 LWTSLDVLCVTASIETLCVIAIDRYLAITSPFRYQSLMTRARAKVIICTVWAISALVSFL 145
Query: 223 PIFLGWYTTHAHQLFRS-HNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + W+ Q + +P C FV NR Y + SS +SF+IP +IMI++ ++Y+EA
Sbjct: 146 PIMMHWWRDEDPQALKCYQDPGCCDFVTNRAYAIASSIISFYIPLLIMIFVALRVYREAK 205
Query: 282 RQEHMLFR 289
Q + R
Sbjct: 206 EQIRKIDR 213
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor
Length = 365
Score = 155 bits (392), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 73/182 (40%), Positives = 115/182 (63%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 48 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCE 107
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 108 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 167
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + N C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 168 PIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 227
Query: 282 RQ 283
RQ
Sbjct: 228 RQ 229
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex
Length = 458
Score = 155 bits (391), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 72/182 (39%), Positives = 114/182 (62%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 24 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAACILMKMWTFGNFWCE 83
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 84 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 143
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 144 PIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 203
Query: 282 RQ 283
RQ
Sbjct: 204 RQ 205
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor
Length = 342
Score = 155 bits (391), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 73/182 (40%), Positives = 115/182 (63%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 25 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCE 84
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 85 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 144
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + N C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 145 PIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 204
Query: 282 RQ 283
RQ
Sbjct: 205 RQ 206
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The
Beta2 Adrenoceptor
Length = 501
Score = 154 bits (390), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 72/182 (39%), Positives = 114/182 (62%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 56 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCE 115
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 116 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 175
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 176 PIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 235
Query: 282 RQ 283
RQ
Sbjct: 236 RQ 237
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G
Protein- Coupled Receptor
Length = 500
Score = 154 bits (390), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 72/182 (39%), Positives = 114/182 (62%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 55 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCE 114
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 115 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 174
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 175 PIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 234
Query: 282 RQ 283
RQ
Sbjct: 235 RQ 236
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs
Protein Complex
Length = 514
Score = 154 bits (389), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 72/182 (39%), Positives = 114/182 (62%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 197 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGNFWCE 256
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 257 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 316
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 317 PIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 376
Query: 282 RQ 283
RQ
Sbjct: 377 RQ 378
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor.
pdb|3NY8|A Chain A, Crystal Structure Of The Human Beta2 Adrenergic Receptor
In Complex With The Inverse Agonist Ici 118,551
pdb|3NY9|A Chain A, Crystal Structure Of The Human Beta2 Adrenergic Receptor
In Complex With A Novel Inverse Agonist
pdb|3NYA|A Chain A, Crystal Structure Of The Human Beta2 Adrenergic Receptor
In Complex With The Neutral Antagonist Alprenolol
Length = 490
Score = 154 bits (389), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 72/182 (39%), Positives = 114/182 (62%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 56 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCE 115
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 116 FWTSIDVLCVTASIWTLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 175
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 176 PIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 235
Query: 282 RQ 283
RQ
Sbjct: 236 RQ 237
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic
Receptor- Fab Complex
Length = 366
Score = 153 bits (386), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 72/182 (39%), Positives = 114/182 (62%), Gaps = 1/182 (0%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
+FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F C+
Sbjct: 49 VFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCE 108
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L SFL
Sbjct: 109 FWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFL 168
Query: 223 PIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEAD 281
PI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++EA
Sbjct: 169 PIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAK 228
Query: 282 RQ 283
RQ
Sbjct: 229 RQ 230
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization
Of A G Protein Coupled Receptor
Length = 309
Score = 152 bits (384), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 72/185 (38%), Positives = 116/185 (62%), Gaps = 1/185 (0%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
++ +FGN+LVI ++ + +L+ +TNYF+ SLA AD+++ + F + + W FG F
Sbjct: 17 LAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGNF 76
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
C+ W S+DV +ASI LC I+VDRY+AI P Y ++TK++ +++ +VW+ L
Sbjct: 77 WCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLT 136
Query: 220 SFLPIFLGWY-TTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYK 278
SFLPI + WY TH + C F N+ Y + SS VSF++P VIM+++Y ++++
Sbjct: 137 SFLPIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQ 196
Query: 279 EADRQ 283
EA RQ
Sbjct: 197 EAKRQ 201
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor
pdb|4DAJ|B Chain B, Structure Of The M3 Muscarinic Acetylcholine Receptor
pdb|4DAJ|C Chain C, Structure Of The M3 Muscarinic Acetylcholine Receptor
pdb|4DAJ|D Chain D, Structure Of The M3 Muscarinic Acetylcholine Receptor
Length = 479
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 63/185 (34%), Positives = 104/185 (56%), Gaps = 12/185 (6%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
I GN+LVIV+ +++L+ + NYF++SLA AD+++ +M + I NRW G CD
Sbjct: 27 IIGNILVIVAFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACD 86
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
+W S+D S+AS+++L IS DRY++I +PL Y T R +M+ + W+ + V +
Sbjct: 87 LWLSIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVI-SFVLWA 145
Query: 223 PIFLGWYTTHAHQLF---RSHNPNSCI--FVVNRIYCVVSSCVSFWIPGVIMIYMYYQIY 277
P L W Q F R+ P C F+ ++ +F++P IM +Y++IY
Sbjct: 146 PAILFW------QYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIY 199
Query: 278 KEADR 282
KE ++
Sbjct: 200 KETEK 204
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex
With Eticlopride
pdb|3PBL|B Chain B, Structure Of The Human Dopamine D3 Receptor In Complex
With Eticlopride
Length = 481
Score = 103 bits (258), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 68/179 (37%), Positives = 102/179 (56%), Gaps = 14/179 (7%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNR-WLFGYFMC 161
+FGN LV ++V++ R L+ TNY VVSLA AD+LVA M + + +E+ W F C
Sbjct: 53 VFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICC 112
Query: 162 DVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKS---RLLIMLCIVWLSPAL 218
DV+ +LDV +ASI +LC IS+DRY A+V P+ Y +S R+ +M+ VW+
Sbjct: 113 DVFVTLDVMMCTASIWNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFA 172
Query: 219 VSFLPIFLGWYTTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIY 277
VS P+ G+ TT + NP+ I+ SS VSF++P + + +Y +IY
Sbjct: 173 VS-CPLLFGFNTTGDPTVCSISNPDFVIY---------SSVVSFYLPFGVTVLVYARIY 221
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex
With Doxepin
Length = 452
Score = 88.2 bits (217), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 98/187 (52%), Gaps = 9/187 (4%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
NLLV+ +V RKL + N ++VSL+ AD++V M N+ + ++W G +C W
Sbjct: 26 NLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWL 85
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL--- 222
S+D S+ASI + + +DRY ++ QPL Y TK+R + W +SFL
Sbjct: 86 SMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAW----FLSFLWVI 141
Query: 223 PIFLGWYTTHAHQLFRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEADR 282
PI LGW R + F + V+++ ++F++P ++M++ Y +IYK A R
Sbjct: 142 PI-LGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYK-AVR 199
Query: 283 QEHMLFR 289
Q +F
Sbjct: 200 QHCNIFE 206
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine
Receptor Bound To An Antagonist
Length = 467
Score = 87.4 bits (215), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 53/183 (28%), Positives = 94/183 (51%), Gaps = 6/183 (3%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCD 162
I GN+LV+VS+ +R L+ + NYF+ SLA AD+++ +M + W G +CD
Sbjct: 38 IIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCD 97
Query: 163 VWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFL 222
+W +LD S+AS+++L IS DRY+ + +PL Y + T +M+ W+ + + +
Sbjct: 98 LWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVL-SFILWA 156
Query: 223 PIFLGWYTTHAHQLFRSHNPNSCI--FVVNRIYCVVSSCVSFWIPGVIMIYMYYQIYKEA 280
P L W R+ C F N ++ +F++P +IM +Y+ I + +
Sbjct: 157 PAILFWQFIVG---VRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRAS 213
Query: 281 DRQ 283
+
Sbjct: 214 KSR 216
>pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed
With Nk1r
pdb|2KSA|A Chain A, Substance P In DmpcCHAPS ISOTROPIC Q0.25 BICELLES AS A
LIGAND FOR Nk1r
pdb|2KSB|A Chain A, Substance P In Isotropic Q0.25 DmpcCHAPSGM1 BICELLES AS A
LIGAND For Nk1r
Length = 364
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 46/168 (27%), Positives = 88/168 (52%), Gaps = 15/168 (8%)
Query: 113 VMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWNSLDVYFS 172
++ H+++R +TNYF+V+LAFA+ +A N + + N W +G F C N +
Sbjct: 57 ILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAV 116
Query: 173 SASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIFLGWYTTH 232
ASI + ++ DRY AI+ PL L T ++++I C++W+ L++F G+Y+T
Sbjct: 117 FASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVI--CVIWVLALLLAFPQ---GYYSTT 171
Query: 233 AHQLFR-------SHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMY 273
R +PN + ++Y + + + +++P +++ Y Y
Sbjct: 172 ETMPSRVVCMIEWPEHPNK---IYEKVYHICVTVLIYFLPLLVIGYAY 216
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor
pdb|3REY|A Chain A, Thermostabilised Adenosine A2a Receptor In Complex With
Xac
pdb|3RFM|A Chain A, Thermostabilised Adenosine A2a Receptor In Complex With
Caffeine
pdb|3UZA|A Chain A, Thermostabilised Adenosine A2a Receptor In Complex With
6-(2,6-
Dimethylpyridin-4-Yl)-5-Phenyl-1,2,4-Triazin-3-Amine
pdb|3UZC|A Chain A, Thermostabilised Adenosine A2a Receptor In Complex With
4-(3-Amino-5- Phenyl-1,2,4-Triazin-6-Yl)-2-Chlorophenol
Length = 329
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V AI GN+LV +V + L+ +TNYFVVSLA AD+LV G + ++ I +
Sbjct: 18 VLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILV--GVLAIPFAITISTGFCAACH 75
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
C + + +SI L I++DRY AI PL Y+ ++T +R ++ I W+ +
Sbjct: 76 GCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAI 135
Query: 220 SFLPIFLGWYTTHAHQLFRSHNPN------SCIF--VVNRIYCV---VSSCVSFWIPGVI 268
P+ LGW + ++H+ +C+F VV Y V +CV +P ++
Sbjct: 136 GLTPM-LGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACV--LVPLLL 192
Query: 269 MIYMYYQIYKEADRQ 283
M+ +Y +I+ A RQ
Sbjct: 193 MLGVYLRIFAAARRQ 207
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In
Complex With Zm241385 At 1.8a Resolution
Length = 447
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 16/195 (8%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V AI GN+LV +V + L+ +TNYFVVSLA AD +A G + ++ I +
Sbjct: 43 VLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAAD--IAVGVLAIPFAITISTGFCAACH 100
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
C + + +SI L I++DRY AI PL Y+ ++T +R ++ I W+ +
Sbjct: 101 GCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAI 160
Query: 220 SFLPIFLGWYTTHAHQLFRSHNPN------SCIF--VVNRIYCV---VSSCVSFWIPGVI 268
P+ LGW + ++H+ +C+F VV Y V +CV +P ++
Sbjct: 161 GLTPM-LGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACV--LVPLLL 217
Query: 269 MIYMYYQIYKEADRQ 283
M+ +Y +I+ A RQ
Sbjct: 218 MLGVYLRIFLAARRQ 232
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine
Receptor Bound To Zm241385.
pdb|3QAK|A Chain A, Agonist Bound Structure Of The Human Adenosine A2a
Receptor
Length = 488
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 16/195 (8%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V AI GN+LV +V + L+ +TNYFVVSLA AD +A G + ++ I +
Sbjct: 33 VLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAAD--IAVGVLAIPFAITISTGFCAACH 90
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
C + + +SI L I++DRY AI PL Y+ ++T +R ++ I W+ +
Sbjct: 91 GCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAI 150
Query: 220 SFLPIFLGWYTTHAHQLFRSHNPN------SCIF--VVNRIYCV---VSSCVSFWIPGVI 268
P+ LGW + ++H+ +C+F VV Y V +CV +P ++
Sbjct: 151 GLTPM-LGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACV--LVPLLL 207
Query: 269 MIYMYYQIYKEADRQ 283
M+ +Y +I+ A RQ
Sbjct: 208 MLGVYLRIFLAARRQ 222
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound
pdb|2YDV|A Chain A, Thermostabilised Human A2a Receptor With Neca Bound
Length = 325
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V AI GN+LV +V + L+ +TNYFVVS A AD+LV G + ++ I +
Sbjct: 18 VLAILGNVLVCWAVWLNSNLQNVTNYFVVSAAAADILV--GVLAIPFAIAISTGFCAACH 75
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
C + +++SI L I++DRY AI PL Y+ ++T +R ++ I W+ +
Sbjct: 76 GCLFIACFVLVLTASSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAI 135
Query: 220 SFLPIFLGWYTTHAHQLFRSHNPN------SCIF--VVNRIYCV---VSSCVSFWIPGVI 268
P+ LGW + ++H+ +C+F VV Y V +CV +P ++
Sbjct: 136 GLTPM-LGWNNCGQPKEGKAHSQGCGEGQVACLFEDVVPMNYMVYFNFFACV--LVPLLL 192
Query: 269 MIYMYYQIYKEADRQ 283
M+ +Y +I+ A RQ
Sbjct: 193 MLGVYLRIFLAARRQ 207
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An
Allosteric Inverse-Agonist Antibody At 2.7 A Resolution
pdb|3VGA|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An
Allosteric Inverse-Agonist Antibody At 3.1 A Resolution
Length = 326
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V AI GN+LV +V + L+ +TNYFVVSLA AD +A G + ++ I +
Sbjct: 18 VLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAAD--IAVGVLAIPFAITISTGFCAACH 75
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
C + + +SI L I++DRY AI PL Y+ ++T +R ++ I W+ +
Sbjct: 76 GCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAI 135
Query: 220 SFLPIFLGWYTTHAHQLFRSHNPN------SCIF--VVNRIYCV---VSSCVSFWIPGVI 268
P+ LGW + + H+ +C+F VV Y V +CV +P ++
Sbjct: 136 GLTPM-LGWNNCGQPKEGKQHSQGCGEGQVACLFEDVVPMNYMVYFNFFACV--LVPLLL 192
Query: 269 MIYMYYQIYKEADRQ 283
M+ +Y +I+ A RQ
Sbjct: 193 MLGVYLRIFLAARRQ 207
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex
With Jdtic
pdb|4DJH|B Chain B, Structure Of The Human Kappa Opioid Receptor In Complex
With Jdtic
Length = 480
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 44/128 (34%), Positives = 66/128 (51%), Gaps = 1/128 (0%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V + GN LV+ ++R+ K++ TN ++ +LA AD LV M F +V + N W FG
Sbjct: 34 VVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVT-TTMPFQSTVYLMNSWPFGDV 92
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
+C + S+D Y SI L +SVDRY A+ P+ T + I+ +WL + V
Sbjct: 93 LCKIVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSV 152
Query: 220 SFLPIFLG 227
I LG
Sbjct: 153 GISAIVLG 160
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A
Morphinan Antagonist
Length = 464
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 1/96 (1%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V +FGN LV+ ++R+ K++ TN ++ +LA AD L A + F + W FG
Sbjct: 29 VVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADAL-ATSTLPFQSVNYLMGTWPFGNI 87
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLD 195
+C + S+D Y SI LC +SVDRY A+ P+
Sbjct: 88 LCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVK 123
>pdb|2Z73|A Chain A, Crystal Structure Of Squid Rhodopsin
pdb|2Z73|B Chain B, Crystal Structure Of Squid Rhodopsin
pdb|3AYM|A Chain A, Crystal Structure Of The Batho Intermediate Of Squid
Rhodopsin
pdb|3AYM|B Chain B, Crystal Structure Of The Batho Intermediate Of Squid
Rhodopsin
pdb|3AYN|A Chain A, Crystal Structure Of Squid Isorhodopsin
pdb|3AYN|B Chain B, Crystal Structure Of Squid Isorhodopsin
Length = 448
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 4/116 (3%)
Query: 115 RHRKLRVITNYFVVSLAFADMLVAFGAMGFNL-SVEIF-NRWLFGYFMCDVWNSLDVYFS 172
+ + L+ N F+++LAF+D + GF L ++ F +W+FG+ C V+ + F
Sbjct: 61 KTKSLQTPANMFIINLAFSDFTFSL-VNGFPLMTISCFLKKWIFGFAACKVYGFIGGIFG 119
Query: 173 SASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIFLGW 228
SI+ + IS+DRY I +P+ M+ R IM+ VWL L + PIF GW
Sbjct: 120 FMSIMTMAMISIDRYNVIGRPMAASKKMSHRRAFIMIIFVWLWSVLWAIGPIF-GW 174
>pdb|2ZIY|A Chain A, Crystal Structure Of Squid Rhodopsin
Length = 372
Score = 63.2 bits (152), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 4/116 (3%)
Query: 115 RHRKLRVITNYFVVSLAFADMLVAFGAMGFNL-SVEIF-NRWLFGYFMCDVWNSLDVYFS 172
+ + L+ N F+++LAF+D + GF L ++ F +W+FG+ C V+ + F
Sbjct: 60 KTKSLQTPANMFIINLAFSDFTFSL-VNGFPLMTISCFLKKWIFGFAACKVYGFIGGIFG 118
Query: 173 SASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIFLGW 228
SI+ + IS+DRY I +P+ M+ R IM+ VWL L + PIF GW
Sbjct: 119 FMSIMTMAMISIDRYNVIGRPMAASKKMSHRRAFIMIIFVWLWSVLWAIGPIF-GW 173
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To
Naltrindole
Length = 461
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 2/111 (1%)
Query: 102 AIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMC 161
+ GN+LV+ ++R+ KL+ TN ++ +LA AD L A + F + + W FG +C
Sbjct: 28 GLLGNVLVMFGIVRYTKLKTATNIYIFNLALADAL-ATSTLPFQSAKYLMETWPFGELLC 86
Query: 162 DVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRL-LIMLCI 211
S+D Y SI L +SVDRY A+ P+ T ++ LI +CI
Sbjct: 87 KAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICI 137
>pdb|4EA3|A Chain A, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A
PEPTIDE Mimetic
pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A
PEPTIDE Mimetic
Length = 434
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 1/137 (0%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
V + GN LV+ ++RH K++ TN ++ +LA AD LV + F + + W FG
Sbjct: 137 VGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLL-TLPFQGTDILLGFWPFGNA 195
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALV 219
+C ++D Y S L +SVDRY AI P+ + T S+ + +W ++V
Sbjct: 196 LCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVV 255
Query: 220 SFLPIFLGWYTTHAHQL 236
+G ++
Sbjct: 256 GVPVAIMGSAQVEDEEI 272
>pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone
pdb|3OAX|B Chain B, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone
pdb|1GZM|A Chain A, Structure Of Bovine Rhodopsin In A Trigonal Crystal Form
pdb|1GZM|B Chain B, Structure Of Bovine Rhodopsin In A Trigonal Crystal Form
pdb|1HZX|A Chain A, Crystal Structure Of Bovine Rhodopsin
pdb|1HZX|B Chain B, Crystal Structure Of Bovine Rhodopsin
pdb|2I36|A Chain A, Crystal Structure Of Trigonal Crystal Form Of Ground-State
Rhodopsin
pdb|2I36|B Chain B, Crystal Structure Of Trigonal Crystal Form Of Ground-State
Rhodopsin
pdb|2I36|C Chain C, Crystal Structure Of Trigonal Crystal Form Of Ground-State
Rhodopsin
pdb|2I35|A Chain A, Crystal Structure Of Rhombohedral Crystal Form Of
Ground-State Rhodopsin
pdb|2I37|A Chain A, Crystal Structure Of A Photoactivated Rhodopsin
pdb|2I37|B Chain B, Crystal Structure Of A Photoactivated Rhodopsin
pdb|2I37|C Chain C, Crystal Structure Of A Photoactivated Rhodopsin
pdb|2HPY|A Chain A, Crystallographic Model Of Lumirhodopsin
pdb|2HPY|B Chain B, Crystallographic Model Of Lumirhodopsin
pdb|2PED|A Chain A, Crystallographic Model Of 9-Cis-Rhodopsin
pdb|2PED|B Chain B, Crystallographic Model Of 9-Cis-Rhodopsin
pdb|2G87|A Chain A, Crystallographic Model Of Bathorhodopsin
pdb|2G87|B Chain B, Crystallographic Model Of Bathorhodopsin
pdb|1L9H|A Chain A, Crystal Structure Of Bovine Rhodopsin At 2.6 Angstroms
Resolution
pdb|1L9H|B Chain B, Crystal Structure Of Bovine Rhodopsin At 2.6 Angstroms
Resolution
pdb|1U19|A Chain A, Crystal Structure Of Bovine Rhodopsin At 2.2 Angstroms
Resolution
pdb|1U19|B Chain B, Crystal Structure Of Bovine Rhodopsin At 2.2 Angstroms
Resolution
Length = 349
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
N L + ++H+KLR NY +++LA AD+ + FG L + ++FG C++
Sbjct: 56 NFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEG 115
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIF 225
++ L ++++RY + +P+ + ++ ++ + W+ AL P
Sbjct: 116 FFATLGGEIALWSLVVLAIERYVVVCKPMS-NFRFGENHAIMGVAFTWVM-ALACAAPPL 173
Query: 226 LGW--YTTHAHQL------FRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQI- 276
+GW Y Q + H + N + + V F IP +++ + Y Q+
Sbjct: 174 VGWSRYIPEGMQCSCGIDYYTPHEETN-----NESFVIYMFVVHFIIPLIVIFFCYGQLV 228
Query: 277 --YKEADRQEH 285
KEA Q+
Sbjct: 229 FTVKEAAAQQQ 239
>pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted)
pdb|1LN6|A Chain A, Structure Of Bovine Rhodopsin (Metarhodopsin Ii)
pdb|3CAP|A Chain A, Crystal Structure Of Native Opsin: The G Protein-Coupled
Receptor Rhodopsin In Its Ligand-Free State
pdb|3CAP|B Chain B, Crystal Structure Of Native Opsin: The G Protein-Coupled
Receptor Rhodopsin In Its Ligand-Free State
pdb|3C9L|A Chain A, Structure Of Ground-State Bovine Rhodospin In A Hexagonal
Crystal Form
pdb|1F88|A Chain A, Crystal Structure Of Bovine Rhodopsin
pdb|1F88|B Chain B, Crystal Structure Of Bovine Rhodopsin
pdb|3DQB|A Chain A, Crystal Structure Of The Active G-protein-coupled Receptor
Opsin In Complex With A C-terminal Peptide Derived From
The Galpha Subunit Of Transducin
pdb|3PQR|A Chain A, Crystal Structure Of Metarhodopsin Ii In Complex With A
C-Terminal Peptide Derived From The Galpha Subunit Of
Transducin
pdb|3PXO|A Chain A, Crystal Structure Of Metarhodopsin Ii
Length = 348
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
N L + ++H+KLR NY +++LA AD+ + FG L + ++FG C++
Sbjct: 55 NFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEG 114
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIF 225
++ L ++++RY + +P+ + ++ ++ + W+ AL P
Sbjct: 115 FFATLGGEIALWSLVVLAIERYVVVCKPMS-NFRFGENHAIMGVAFTWVM-ALACAAPPL 172
Query: 226 LGW--YTTHAHQL------FRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQI- 276
+GW Y Q + H + N + + V F IP +++ + Y Q+
Sbjct: 173 VGWSRYIPEGMQCSCGIDYYTPHEETN-----NESFVIYMFVVHFIIPLIVIFFCYGQLV 227
Query: 277 --YKEADRQEH 285
KEA Q+
Sbjct: 228 FTVKEAAAQQQ 238
>pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c,
D282c Rhodopsin Mutant With Bound Galphact Peptide
Length = 349
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
N L + ++H+KLR NY +++LA AD+ + FG L + ++FG C++
Sbjct: 56 NFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLQG 115
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIF 225
++ L ++++RY + +P+ + ++ ++ + W+ AL P
Sbjct: 116 FFATLGGEIALWSLVVLAIERYVVVCKPMS-NFRFGENHAIMGVAFTWVM-ALACAAPPL 173
Query: 226 LGW--YTTHAHQL------FRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQI- 276
+GW Y Q + H + N + + V F IP +++ + Y Q+
Sbjct: 174 VGWSRYIPEGMQCSCGIDYYTPHEETN-----NESFVIYMFVVHFIIPLIVIFFCYGQLV 228
Query: 277 --YKEADRQEH 285
KEA Q+
Sbjct: 229 FTVKEAAAQQQ 239
>pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant
Expressed In Mammalian Cells
pdb|2J4Y|B Chain B, Crystal Structure Of A Rhodopsin Stabilizing Mutant
Expressed In Mammalian Cells
Length = 349
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
N L + ++H+KLR NY +++LA AD+ + FG L + ++FG C++
Sbjct: 56 NFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEG 115
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIF 225
++ L ++++RY + +P+ + ++ ++ + W+ AL P
Sbjct: 116 FFATLGGEIALWSLVVLAIERYVVVCKPMS-NFRFGENHAIMGVAFTWVM-ALACAAPPL 173
Query: 226 LGW--YTTHAHQL------FRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQI- 276
+GW Y Q + H + N + + V F IP +++ + Y Q+
Sbjct: 174 VGWSRYIPEGMQCSCGIDYYTPHEETN-----NESFVIYMFVVHFIIPLIVIFFCYGQLV 228
Query: 277 --YKEADRQEH 285
KEA Q+
Sbjct: 229 FTVKEAAAQQQ 239
>pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal
Crystal Form
Length = 348
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
N L + ++H+KLR NY +++LA AD+ + FG L + ++FG C++
Sbjct: 55 NFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEG 114
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIF 225
++ L ++++RY + +P+ + ++ ++ + W+ AL P
Sbjct: 115 FFATLGGEIALWSLVVLAIERYVVVCKPMS-NFRFGENHAIMGVAFTWVM-ALACAAPPL 172
Query: 226 LGW--YTTHAHQL------FRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQI- 276
+GW Y Q + H + N + + V F IP +++ + Y Q+
Sbjct: 173 VGWSRYIPEGMQCSCGIDYYTPHEETN-----NESFVIYMFVVHFIIPLIVIFFCYGQLV 227
Query: 277 --YKEADRQEH 285
KEA Q+
Sbjct: 228 FTVKEAAAQQQ 238
>pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively
Active N2c,M257y,D282c Rhodopsin Mutant In Complex With
A Peptide Resembling The C-Terminus Of The
Galpha-Protein Subunit (Gact)
Length = 349
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYFMCDVWN 165
N L + ++H+KLR NY +++LA AD+ + FG L + ++FG C++
Sbjct: 56 NFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEG 115
Query: 166 SLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPIF 225
++ L ++++RY + +P+ + ++ ++ + W+ AL P
Sbjct: 116 FFATLGGEIALWSLVVLAIERYVVVCKPMS-NFRFGENHAIMGVAFTWVM-ALACAAPPL 173
Query: 226 LGW--YTTHAHQL------FRSHNPNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMYYQI- 276
+GW Y Q + H + N + + V F IP +++ + Y Q+
Sbjct: 174 VGWSRYIPEGMQCSCGIDYYTPHEETN-----NESFVIYMFVVHFIIPLIVIFFCYGQLV 228
Query: 277 --YKEADRQEH 285
KEA Q+
Sbjct: 229 FTVKEAAAQQQ 239
>pdb|3ODU|A Chain A, The 2.5 A Structure Of The Cxcr4 Chemokine Receptor In
Complex With Small Molecule Antagonist It1t
pdb|3ODU|B Chain B, The 2.5 A Structure Of The Cxcr4 Chemokine Receptor In
Complex With Small Molecule Antagonist It1t
pdb|3OE8|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In
Complex With A Small Molecule Antagonist It1t In P1
Spacegroup
pdb|3OE8|B Chain B, Crystal Structure Of The Cxcr4 Chemokine Receptor In
Complex With A Small Molecule Antagonist It1t In P1
Spacegroup
pdb|3OE8|C Chain C, Crystal Structure Of The Cxcr4 Chemokine Receptor In
Complex With A Small Molecule Antagonist It1t In P1
Spacegroup
Length = 502
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
++ I GN LVI+ + +KLR +T+ + + L+ AD+L + F +V+ W FG F
Sbjct: 60 LTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVI-TLPF-WAVDAVANWYFGNF 117
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLS---P 216
+C + + +S+ L IS+DRY AIV + + R L+ +V++ P
Sbjct: 118 LCKAVHVIYTVNLYSSVWILAFISLDRYLAIVHATNSQ----RPRKLLAEKVVYVGVWIP 173
Query: 217 ALVSFLPIFLGWYTTHAHQLFRSHN--PNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMY 273
AL+ +P F+ + A + PN VV + ++ V +PG++++ Y
Sbjct: 174 ALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIM---VGLILPGIVILSCY 229
>pdb|3OE6|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In
Complex With A Small Molecule Antagonist It1t In I222
Spacegroup
Length = 508
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
++ I GN LVI+ + +KLR +T+ + + L+ AD+L + F +V+ W FG F
Sbjct: 60 LTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVI-TLPF-WAVDAVANWYFGNF 117
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLS---P 216
+C + + +S+ L IS+DRY AIV + + R L+ +V++ P
Sbjct: 118 LCKAVHVIYTVNLYSSVWILAFISLDRYLAIVHATNSQ----RPRKLLAEKVVYVGVWIP 173
Query: 217 ALVSFLPIFLGWYTTHAHQLFRSHN--PNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMY 273
AL+ +P F+ + A + PN VV + ++ V +PG++++ Y
Sbjct: 174 ALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIM---VGLILPGIVILSCY 229
>pdb|3OE0|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In
Complex With A Cyclic Peptide Antagonist Cvx15
pdb|3OE9|A Chain A, Crystal Structure Of The Chemokine Cxcr4 Receptor In
Complex With A Small Molecule Antagonist It1t In P1
Spacegroup
pdb|3OE9|B Chain B, Crystal Structure Of The Chemokine Cxcr4 Receptor In
Complex With A Small Molecule Antagonist It1t In P1
Spacegroup
Length = 499
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 100 VSAIFGNLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNRWLFGYF 159
++ I GN LVI+ + +KLR +T+ + + L+ AD+L + F +V+ W FG F
Sbjct: 60 LTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVI-TLPF-WAVDAVANWYFGNF 117
Query: 160 MCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLS---P 216
+C + + +S+ L IS+DRY AIV + + R L+ +V++ P
Sbjct: 118 LCKAVHVIYTVNLYSSVWILAFISLDRYLAIVHATNSQ----RPRKLLAEKVVYVGVWIP 173
Query: 217 ALVSFLPIFLGWYTTHAHQLFRSHN--PNSCIFVVNRIYCVVSSCVSFWIPGVIMIYMY 273
AL+ +P F+ + A + PN VV + ++ V +PG++++ Y
Sbjct: 174 ALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIM---VGLILPGIVILSCY 229
>pdb|2LNL|A Chain A, Structure Of Human Cxcr1 In Phospholipid Bilayers
Length = 296
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/75 (37%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 152 NRWLFGYFMCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCI 211
N W+FG F+C V + L + IL L CISVDRY AIV + K L+ +C+
Sbjct: 73 NGWIFGTFLCKVVSLLKEVNFYSGILLLACISVDRYLAIVHA--TRTLTQKRHLVKFVCL 130
Query: 212 VWLSPALVSFLPIFL 226
++ LP FL
Sbjct: 131 GCWGLSMNLSLPFFL 145
>pdb|4GRV|A Chain A, The Crystal Structure Of The Neurotensin Receptor Nts1 In
Complex With Neurotensin (8-13)
Length = 510
Score = 40.8 bits (94), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 146 LSVEIFN------RWLFGYFMCDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLI 199
+ VE++N W FG C + L + A+ L++ +SV RY AI P +
Sbjct: 89 MPVELYNFIWVHHPWAFGDAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTL 148
Query: 200 MTKSRLLIMLCIVWLSPALVSFLPIF 225
M++SR + +WL+ AL++ +F
Sbjct: 149 MSRSRTKKFISAIWLASALLAIPMLF 174
>pdb|1HLL|A Chain A, Nmr Structure Of T3-I2, A 32 Residue Peptide From The
Alpha- 2a Adrenergic Receptor
Length = 32
Score = 38.9 bits (89), Expect = 0.004, Method: Composition-based stats.
Identities = 16/32 (50%), Positives = 25/32 (78%)
Query: 173 SASILHLCCISVDRYYAIVQPLDYHLIMTKSR 204
++SI+HLC IS+DRY++I Q ++Y+L T R
Sbjct: 1 TSSIVHLCAISLDRYWSITQAIEYNLKRTPRR 32
>pdb|1HOF|A Chain A, Nmr Structure Of T3-I2, A 32 Residue Peptide From The
Alpha- 2a Adrenergic Receptor
Length = 32
Score = 38.1 bits (87), Expect = 0.005, Method: Composition-based stats.
Identities = 16/31 (51%), Positives = 24/31 (77%)
Query: 174 ASILHLCCISVDRYYAIVQPLDYHLIMTKSR 204
+SI+HLC IS+DRY++I Q ++Y+L T R
Sbjct: 2 SSIVHLCAISLDRYWSITQAIEYNLKRTPRR 32
>pdb|1HO9|A Chain A, Best 20 Nmr Conformers Of D130i Mutant T3-I2, A 32 Residue
Peptide From The Alpha 2a Adrenergic Receptor
pdb|1HOD|A Chain A, Nmr Structure Of D130i Mutant T3-I2, A 32 Residue Peptide
From The Alpha 2a Adrenergic Receptor
Length = 32
Score = 35.0 bits (79), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 23/31 (74%)
Query: 174 ASILHLCCISVDRYYAIVQPLDYHLIMTKSR 204
+SI+HLC IS+ RY++I Q ++Y+L T R
Sbjct: 2 SSIVHLCAISLIRYWSITQAIEYNLKRTPRR 32
>pdb|3V2W|A Chain A, Crystal Structure Of A Lipid G Protein-Coupled Receptor At
3.35a
pdb|3V2Y|A Chain A, Crystal Structure Of A Lipid G Protein-Coupled Receptor At
2.80a
Length = 520
Score = 33.9 bits (76), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 7/128 (5%)
Query: 103 IFGNLLVIVSVMRHRKLRVITNYFVVSLAFADML--VAFGAMGFNLSVEIFNRWLFGYFM 160
I N+ V++++ + +K YF+ +LA +D+L VA+ A + +F+
Sbjct: 78 ILENIFVLLTIWKTKKFHRPMYYFIGNLALSDLLAGVAYTANLLLSGATTYKLTPAQWFL 137
Query: 161 CDVWNSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVS 220
+ S+ V SAS+ L I+++RY +++ + H RL +++ W+ ++
Sbjct: 138 RE--GSMFVAL-SASVFSLLAIAIERYITMLK-MKLHNGSNNFRLFLLISACWVISLILG 193
Query: 221 FLPIFLGW 228
LPI +GW
Sbjct: 194 GLPI-MGW 200
>pdb|3VW7|A Chain A, Crystal Structure Of Human Protease-Activated Receptor 1
(Par1) Bound With Antagonist Vorapaxar At 2.2 Angstrom
Length = 484
Score = 32.3 bits (72), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 34/132 (25%), Positives = 57/132 (43%), Gaps = 3/132 (2%)
Query: 106 NLLVIVSVMRHRKLRVITNYFVVSLAFADMLVAFGAMGFNLSVEIFNR-WLFGYFMCDVW 164
N++ IV + K++ +++ LA AD+L + F +S W FG +C
Sbjct: 38 NIMAIVVFILKMKVKKPAVVYMLHLATADVLFV-SVLPFKISYYFSGSDWQFGSELCRFV 96
Query: 165 NSLDVYFSSASILHLCCISVDRYYAIVQPLDYHLIMTKSRLLIMLCIVWLSPALVSFLPI 224
+ ASIL + IS+DR+ A+V P+ T R +W + A+ +P+
Sbjct: 97 TAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIW-ALAIAGVVPL 155
Query: 225 FLGWYTTHAHQL 236
L T L
Sbjct: 156 LLKEQTIQVPGL 167
>pdb|2B39|A Chain A, Structure Of Mammalian C3 With An Intact Thioester At 3a
Resolution
pdb|2B39|B Chain B, Structure Of Mammalian C3 With An Intact Thioester At 3a
Resolution
Length = 1661
Score = 31.6 bits (70), Expect = 0.51, Method: Composition-based stats.
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 16/70 (22%)
Query: 234 HQLFRSHNPNSCIFVVNRIYCVVSSCVSFWI----------PGVIMIYMYYQI------Y 277
+++ R N N+ I ++++ V C+SF + PG + +Y YY + +
Sbjct: 1431 YEMNRDSNKNTLIIYLDKVSHTVEDCLSFKVHQYFNVGLIQPGAVKVYSYYNLDETCIRF 1490
Query: 278 KEADRQEHML 287
D+++ ML
Sbjct: 1491 YHPDKEDGML 1500
>pdb|3EE1|A Chain A, Novel Fold Of Vira, A Type Iii Secretion System Effector
Protein From Shigella Flexneri
pdb|3EE1|B Chain B, Novel Fold Of Vira, A Type Iii Secretion System Effector
Protein From Shigella Flexneri
Length = 400
Score = 28.5 bits (62), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 15/52 (28%), Positives = 24/52 (46%), Gaps = 8/52 (15%)
Query: 27 HTLTAAIAPTLRKPNASIYFTNGSVFNYLLTEANATSGVISNDSYFPLYDYD 78
HT+TA ++ + T+ + T N + +I ND YFP+ D D
Sbjct: 135 HTITAPVSGNFK--------THKPAPEVIETAINCCTSIIPNDDYFPVKDTD 178
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.331 0.140 0.446
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,325,044
Number of Sequences: 62578
Number of extensions: 256447
Number of successful extensions: 568
Number of sequences better than 100.0: 45
Number of HSP's better than 100.0 without gapping: 43
Number of HSP's successfully gapped in prelim test: 2
Number of HSP's that attempted gapping in prelim test: 490
Number of HSP's gapped (non-prelim): 46
length of query: 289
length of database: 14,973,337
effective HSP length: 98
effective length of query: 191
effective length of database: 8,840,693
effective search space: 1688572363
effective search space used: 1688572363
T: 11
A: 40
X1: 15 ( 7.2 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.9 bits)
S2: 51 (24.3 bits)